Viruses are obligate intracellular parasites which can cause a spectrum of disease from asymptomatic persistent infection to fatal illness. The need to resist virus infection has been a major driving force in the evolution of the immune system, in particular of those facets of the immune response involved in the recognition of foreign antigens on the surface of cells. From the time of Jenner\'s observation that exposure to cowpox gave protection, or immunity, against smallpox, the study of viruses has prompted research in immunology, and the disciplines of virology and immunology continue to be closely interrelated. For instance, a considerable amount of work in immunology is still driven by the need to produce vaccines to protect against current pathogens, such as human immunodeficiency virus (HIV). Detailed studies of individual viruses (such as influenza) have made important contributions to the understanding of molecular recognition of antigen by T cells, and recombinant vaccinia viruses provide a research tool for introducing foreign antigens into cells. As well as producing tissue damage by direct cytopathic effects, viruses may also evoke immune responses which are harmful to the host; these may include responses directed primarily against virus-infected cells (in which uninfected bystander cells may also be damaged), and autoimmune responses against uninfected cells.

Viruses as antigens {#s0005}
===================

Viruses consist of a central core of nucleic acid which may be RNA or DNA, and single- or double-stranded. This is surrounded by a coat (capsid) of repeating protein subunits (capsomers). In most viruses, the capsomers are arranged symmetrically around the nucleic acid, either as an icosahedron or as a helix. Some viruses also have a lipid envelope derived from the host cell membrane into which viral glycoproteins are inserted. The structure of some smaller viruses (such as polio), and component proteins of more complex viruses (such as influenza hemagglutinin, HA) has been solved at high resolution by X-ray crystallography. Viruses are classified according to the type of nucleic acid making up the genome, whether the genome is segmented or not, and the presence or absence of an outer envelope. Viral genomes vary in size from very small (such as parvovirus with 5 kb of single-stranded DNA) to large (such as poxviruses with up to 280 kb of double-stranded DNA).

Viral infection begins with the attachment of the virus to a component of the cell membrane which acts as its specific receptor, such as the CD4 molecule on T cells to which HIV binds, or sialic acid for the influenzavirus hemagglutinin. Enveloped viruses may penetrate the cell by fusion with the cell membrane (mediated by fusogenic viral glycoproteins, e.g. Sendai virus) or by endocytosis after binding to their specific receptor (e.g. influenza). In the latter case, the virus then enters the cytoplasm by fusion with the endosomal membrane following an acidic pH-dependent cleavage of viral glycoproteins. Viruses are then uncoated allowing transcription and translation of viral nucleic acids (single positive-stranded RNA viruses are translated directly). In more complex viruses, some of the viral proteins expressed in the infected cell do not form part of the virion; these nonstructural proteins serve functions such as regulating the transcription of other viral and cellular genes, and shutting down synthesis of host cell proteins. Other viral proteins are structural and are incorporated into new virions. Following viral nucleic acid replication, virus particles are assembled by aggregation of structural proteins around the nucleic acid. Nonenveloped viruses may be released from the cell by lysis, whereas enveloped viruses insert their viral glycoproteins into the host cell membrane and bud from the cell surface.

The immune response to viruses {#s0010}
==============================

Studies of patients with isolated immunodeficiencies give an insight into the relative importance of the different components of the immune response. Individuals with isolated defects of cell-mediated immunity develop severe, sometimes fatal viral infections such as measles and chickenpox. A single case of natural killer (NK) cell deficiency has been reported, with increased susceptibility to severe primary herpesvirus infections. Those subjects with isolated immunoglobulin deficiency recover normally from most viral infections, except enteroviruses (which may cause chronic central nervous system infection). Such 'experiments of nature' coupled with an extensive body of experimental work in animal models permit the following generalizations.

Antibodies appear to act principally by neutralizing virions (i.e. rendering virions noninfectious), whereas cell-mediated responses are directed against virus antigens present in the infected cell. Antibody is important in preventing primary infection and reinfection, by neutralizing viruses on mucosal surfaces and limiting their dissemination in body fluids, while cell-mediated immunity seems to be responsible for eliminating intracellular infection and limiting reactivation of persistent viruses.

The immune response may be divided into three phases (see [Table 1](#t0005){ref-type="table"} ) and into humoral and cell-mediated components, which include specific and nonspecific mechanisms.Table 1Phases of the immune response against virus infection*PhaseCharacteristicsMechanism*Immediate \<4 hNonspecific, innateNK cellsNo memoryNo specific T cellsEarly 4--96 hNonspecific, inducibleIFNα, IFNβNo memoryIFN-activated NK cellsNo specific T cellsLate \>96 hSpecific, inducibleAntibodyMemoryCytotoxic T cellsSpecific T cellsCytokine-secreting T cells[^1]

Nonspecific immunity (natural killer cells and interferons) {#s0015}
===========================================================

Natural killer (NK) cells are large granular lymphocytes (CD16^+^, CD56^+^ but without an expressed T cell receptor or CD3), which are able to kill virus-infected cells without prior exposure to that virus. NK cell recognition of virus-infected cells differs from the classical major histocompatibility complex (MHC) restriction of T cells, but is affected by MHC molecule expression; the lower the level of MHC class I expression on the surface of the target cells, the greater their susceptibility to killing by NK cells. This is because specific MHC class I alleles on the surface of target cells can *inhibit* killing by defined NK cell clones, and thus normal levels of expression of certain autologous MHC class I molecules may protect uninfected host cells from being killed by NK cells.

NK cells are activated by interferon α (IFNα) and IFNβ released by virus-infected cells, and by certain viral glycoproteins, e.g. mumps hemagglutinin. Virus-infected cells show increased susceptibility to NK cell lysis compared to uninfected cells. The reasons for this are not fully understood, although several mechanisms have been proposed. These include enhanced binding of NK cells to virus-infected cells; increased susceptibility of infected cells to NK killing due to inhibition of host cell RNA and protein synthesis; altered surface expression of host cell proteins (e.g. reduced surface expression of MHC class I); and the protective effects of IFNs on noninfected cells. Natural killer lysis is not prevented by blocking the synthesis or surface expression of structural viral proteins.

It is thought the NK cells are an important defense mechanism early in the course of viral infection, before specific cytotoxic T lymphocytes (CTLs) and antibody responses have fully developed. In experimental models, NK cells seem to be more important in resistance to certain viral infections, such as herpesviruses, than to others. In mice, for example, NK cells protect against murine cytomegalovirus (MCMV), but not against lymphocytic choriomeningitis virus (LCMV).

Type I interferons (IFNα and IFNβ) are proteins produced by a wide variety of cell types in response to virus infection and other stimuli such as double-stranded RNA. IFNα and IFNβ bind to a common receptor on the surface of uninfected cells and produce an 'antiviral state' by stimulating synthesis of cellular proteins which interfere with viral RNA transcription and translation. Type I IFNs are completely nonspecific, and are produced in response to, and against, a wide range of viruses. The importance of IFNα and IFNβ in host resistance to viruses is clearly illustrated by transgenic mice which lack a functional type I IFN receptor; these animals show greatly increased susceptibility to acute virus infection, leading to death within 3 days of infection associated with very high titers of virus in many organs. The type II interferon IFNγ is produced by NK cells and by T cells on exposure to specific antigen, and activates monocytes and macrophages, enhancing their ability to process and present antigen. IFNs also activate NK cells and the effector cells responsible for antibody-dependent cellular cytotoxicity (ADCC) and give rise to many of the systemic symptoms associated with viral infections, such as fever, malaise and myalgia. Tumor necrosis factor α (TNFα) also has an antiviral effect which may be synergistic with that of IFNs.

Humoral response {#s0020}
================

The major class of virus-specific antibody is immunoglobulin G (IgG). IgM is also produced during the early phase of primary infection, and secretory IgA is important in prevention of viral entry via mucosal surfaces. Virus-specific antibodies may bind to viral epitopes on the surface of the virion, or to viral glycoproteins expressed on the surface of the infected cell. In order to neutralize the virion, a specific antibody must bind with high avidity to particular epitopes on viral proteins that interact with cell surface receptors. While antibodies can be raised against individual small linear peptides derived from a viral glycoprotein such as influenza hemagglutinin, these antibodies are frequently non-neutralizing; many or most neutralization epitopes are probably conformational ones. Antibody may also limit the spread of infection by agglutination of virions (reducing the number of infectious units), and by enhancing the phagocytosis of virions by mononuclear phagocytes (opsonization).

Antibody may also recruit other effector systems. *In vitro*, antibody attached to viral glycoproteins may lead to complement-mediated lysis of the infected cell and of enveloped virions. Certain cells with Fc receptors (CD16^+^ cells such as NK cells and monocytes) may bind to the Fc portion of virus-specific antibodies bound to viral glycoproteins on the cell surface and subsequently lyse the infected cell by ADCC. The precise importance of ADCC and complement-mediated lysis of virus-infected cells *in vivo* is unclear.

Complement enhances the effect of neutralizing antibody by coating the surface of sensitized virions preventing their interaction with cellular receptors. Complement also acts as an opsonin for phagocytic cells. Some viruses may activate complement directly by the alternative pathway.

Specific cell-mediated responses {#s0025}
================================

Virus-specific CTLs are predominantly CD8^+^ in phenotype, although approximately 10% of human peripheral blood CD4^+^ T cells are potentially cytotoxic and capable of giving rise to virus-specific CTLs. CTLs recognize viral antigens which have been processed and presented as peptides on the surface of infected cells by the appropriate MHC molecules; class I in the case of CD8^+^ T cells, class II for CD4^+^ T cells. Processing and presentation of viral antigen allows viral proteins not otherwise expressed on the cell surface to be exposed to T cells, e.g. influenza nucleoprotein. Hence, an infected cell can be recognized and killed by T cells before the virus can replicate, thereby limiting the spread of the infection. Whilst recognition of viral antigen by T cells requires interaction between the T cell receptor and the MHC--antigen complex, interactions between accessory molecules including LFA-1 and ICAM-1, and LFA-3 and CD2 facilitate effector T cell binding to a virus-infected cell. With a few exceptions such as reovirus, CTLs are not serotype specific, i.e. they do not recognize the same epitopes as virus-specific antibodies. The ability of CTLs to confer protection against viral disease can be demonstrated by adoptive transfer in many experimental virus models; for example, naive mice can be protected against lethal influenza A by prior transfer of an influenza A-specific CTL clone. The T cell response to virus infection includes cytotoxic effector T cells and an expanded population of virus-specific memory T cells. After clearance of an acute virus infection (e.g. influenza, in which viral antigen is completely eradicated), effector T cells rapidly disappear, and the size of the memory T cell population may gradually diminish over time. In contrast, in many persistent virus infections (e.g. Epstein--Barr virus (EBV), human cytomegalovirus (HCMV)), virus-specific memory CTL precursors remain at high frequency for many years, and probably play a role in controlling the reactivation of persistent virus and maintaining the normal equilibrium between virus and host.

CD4^+^ T cells may recognize multiple epitopes within a given viral protein, such as influenza HA, and these epitopes may differ from those recognized by antibody. CD4^+^ T cells augment T cell, B cell and NK cell responses to viral proteins through secretion of cytokines including IL-2, IL-12 and IFNγ. Cytokines secreted by subpopulations of virus-specific CD4^+^ T cells and CD8^+^ CTLs contribute to the generation of the delayed-type hypersensitivity (DTH) response, an inflammatory reaction characterized by a mononuclear cell infiltrate of activated lymphocytes and macrophages. In some experimental virus infections, DTH responses can confer resistance to infection; in response to local infection with herpes simplex virus (HSV) inoculated into the ear pinna in mice, CD4^+^ T lymphocytes from the draining lymph nodes proliferate in response to HSV antigens, mediate DTH and upon adoptive transfer can mediate protection against HSV in naive mice. However, DTH can sometimes be harmful. Mice which have previously been exposed to noninfectious influenzavirus suffer increased mortality when they are subsequently challenged with live influenzavirus; adoptive transfer experiments have shown that induction of strong DTH (by prior exposure to noninfectious virus) may be responsible for this observed increase in mortality.

*In vivo*, the different T cell populations obviously interact together rather than producing effects in isolation, and can show considerable plasticity. Transgenic mice that lack β~2~-microglobulin (which results in grossly impaired CD8^+^ T cell development), are able to resist infections by induction of increased numbers of virus-specific CD4^+^ CTLs.

Persistent viral infections {#s0030}
===========================

Many viruses are able to maintain long-term infections which are often symptomless. This may involve chronic production of infectious virus, or latent infection with intermittent reactivation leading to virion production. Certain viruses may exhibit both patterns dependent on host cell type -- for example, hepatitis B virus appears to latently infect lymphocytes but produces infectious virus in hepatocytes. In order to establish a successful persistent infection, a virus should minimize damage of host cells. Certain noncytopathic viruses such as the murine arenavirus LCMV replicate with little apparent disruption of cell function. Other viruses have evolved different strategies that can reduce their lytic potential. These include restricted virus gene expression (in the herpesviruses during their latent nonlytic infection of neuronal or lymphoid cells); the generation of mutant viral strains which do not cause cell lysis (in reovirus after *in vitro* passage in fibroblast lines); and infections where only a small percentage of cells are infected at any one time (in lactic dehydrogenase virus in mice).

The persistent virus also has to evade detection and elimination by the host immune system. Various mechanisms have been described for this, although their relative importance is not known. Some viruses exhibit antigenic variation which presents the immune system with a continually moving target, best demonstrated in chronic infections by the lenti-retrovirus equine infectious anemia virus. An excess of non-neutralizing antibody has been found in some chronic viral infections, which may interfere with neutralizing antibody function. A number of viruses are now recognized to encode genes which downregulate the surface expression of class I MHC molecules through a variety of mechanisms (see [Table 2](#t0010){ref-type="table"} ).Table 2Examples of viral molecules which modulate host immune responses*VirusGene productMechanismInterference with antigen presentation*HSVICP 47Inhibition of peptide transport by TAP1/TAP2 complexHCMVUS 3Retention of class I molecules in endoplasmic reticulumAdenoE3Retention of class I molecules in endoplasmic reticulum*Virus-encoded cytokines*EBVBCRF-1Homology to IL-10H. saimiriHVS-13Homology to IL-16 (CTLA8)VacciniaVGFHomology to epidermal growth factor*Modulation of host cytokines*VacciniaB18RSoluble receptor for IFNα, IFNβVacciniaE3LInhibition of activation of IFN-inducible cellular kinase DAIVacciniaK3LCompetitive inhibition of cellular kinase DAIHCMVUS 28Membrane-bound receptor for C-C chemokines[^2]

Persistent viruses frequently infect immunocompetent cells, thereby compromising their function and preventing elimination of the virus, for example HIV infection of CD4^+^ T cells and dendritic cells. Certain viruses are more likely to establish persistent infection if infection occurs very early in life when the immune system is immature. Infections *in utero* or at birth in mice may be associated with selective impairment of virus-specific immune responses, e.g. neonatal infection with LCMV is accompanied by a defect in the LCMV-specific CD8^+^ CTL response, that can be restored by adoptive transfer of CD8^+^ CTLs from LCMV immune normal adults.

It is likely that several mechanisms for avoiding the host immune response are active in any given persistent virus infection.

Viral immunopathology {#s0035}
=====================

The immune response to viruses may also inflict damage on host cells, as a result of immune responses directed against virus-infected cells, or as a result of indirect mechanisms that damage uninfected cells. In addition, a number of viruses can alter immune responses by infecting immunocompetent cells.

In immunocompetent adult mice that are infected with noncytopathic LCMV, virus-specific cytotoxic T cells induce immunopathology by attacking virus-infected cells in the brain, causing a lethal choriomeningitis; the meningitis can be prevented by immunosuppression with cyclophosphamide. Virus-specific CTLs may contribute to the liver damage seen in chronic hepatitis B virus infection (although in this infection, immunosuppression *worsens* the clinical outcome). Mice experimentally infected with coxsackie B virus develop inflammatory myocarditis which is reduced by T cell depletion, and is abolished in transgenic mice lacking the proinflammatory C-C chemokine MIP-1α. In addition, DTH cells have been shown to enhance tissue damage in mice infected with influenza-virus.

It is believed that the adverse reactions evoked by certain killed virus vaccines when the vaccine recipients encountered the natural infection (particularly respiratory syncytial virus and measles virus) may have resulted from an immunopathological mechanism such as DTH or Arthus reaction.

The generation of non-neutralizing antibodies to certain viruses may have a pathological effect. Non-neutralizing antibody to flaviviruses such as dengue virus can facilitate their entry into macrophages via Fc receptors, where they replicate. Immune complexes are frequently found in many viral infections, e.g. in acute hepatitis B virus infection, immune complexes may be responsible for the arthralgia and rash seen in 10--20% of cases. Immune complexes also occur in chronic hepatitis B virus infection, although only a small proportion of these patients develop vasculitis or chronic glomerulonephritis. It has been suggested that certain human chronic diseases with immunological abnormalities, e.g. chronic immune complex diseases of unknown etiology and multiple sclerosis, might have an underlying viral etiology.

There has been much speculation that viruses may initiate or promote autoimmune disease. Several mechanisms by which this may occur have been suggested. These include generation of anti-idiotypic antibodies against antiviral antibodies which could react with host cells; molecular mimicry, where virus and host share antigenic determinants; promotion of endogenous antigen presentation in virus-infected cells; and impairment of normal immune response suppressor mechanisms. In general there is little direct evidence in support of any of these theories to date. However mice infected with reovirus develop transient diabetes and weight loss in association with autoantibodies to islet and anterior pituitary cells, and these abnormalities can be prevented by immunosuppression with cyclophosphamide.

*See also:* {#mc0215}
===========

Adenovirus, Infection and Immunity; Antibody-dependent Cellular Cytotoxicity; Arenavirus, Infection and Immunity; Arthus Reaction; Autoimmune Disease, Pathogenesis; *Bunyavirus*, Infection and Immunity; Calicivirus, Infection and Immunity; Coronavirus, Infection and Immunity; Hepatitis B Virus, Infection and Immunity; Cytomegalovirus, Infection and Immunity; Cytotoxic T Lymphocytes; Delayed-type Hypersensitivity; Epstein-Barr Virus, Infection and Immunity; Filoviruses (marburg Virus and Ebola Virus), Infection and Immunity; Hepatitis A Virus, Infection and Immunity; Hepatitis C Virus, Infection and Immunity; Hepatitis E, F and G Viruses, Infection and Immunity; Herpes Simplex Virus, Infection and Immunity; Herpesvirus-6, Infection and Immunity; Human Immunodeficiency Viruses; Interferon α; Interferon β; Interferon γ; Iridovirus, Infection and Immunity; Transmissible Spongiform Encephalopathies, Infection and Immunity; Leukemia Viruses; Natural Killer (NK) Cells; Opsonization; Influenza Virus (*orthomyxovirus*), Infection and Immunity; Papillomavirus, Infection And Immunity; Paramyxoviruses, Infection And Immunity; Parvovirus, Infection and Immunity; Phagocytosis; Picornavirus, Infection and Immunity; Polyomavirus, Infection and Immunity; Poxvirus, Infection and Immunity; Reovirus, Infection and Immunity; Retrovirus, Infection and Immunity; Rhabdovirus, Infection and Immunity; Togavirus, Infection and Immunity; Tumor Necrosis Factor α; Vaccines; Varicella-zoster Virus, Infection and Immunity; Viruses, Infection of Immune Cells by.

[^1]: IFN, interferon.

[^2]: DAI, **d**ouble-stranded RNA **a**ctivated **i**nhibitor of translation.
